Correlation Between Oil Natural and Jagsonpal Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oil Natural and Jagsonpal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oil Natural and Jagsonpal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oil Natural Gas and Jagsonpal Pharmaceuticals Limited, you can compare the effects of market volatilities on Oil Natural and Jagsonpal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oil Natural with a short position of Jagsonpal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oil Natural and Jagsonpal Pharmaceuticals.

Diversification Opportunities for Oil Natural and Jagsonpal Pharmaceuticals

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Oil and Jagsonpal is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Oil Natural Gas and Jagsonpal Pharmaceuticals Limi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jagsonpal Pharmaceuticals and Oil Natural is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oil Natural Gas are associated (or correlated) with Jagsonpal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jagsonpal Pharmaceuticals has no effect on the direction of Oil Natural i.e., Oil Natural and Jagsonpal Pharmaceuticals go up and down completely randomly.

Pair Corralation between Oil Natural and Jagsonpal Pharmaceuticals

Assuming the 90 days trading horizon Oil Natural Gas is expected to under-perform the Jagsonpal Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Oil Natural Gas is 73.26 times less risky than Jagsonpal Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Jagsonpal Pharmaceuticals Limited is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  18,290  in Jagsonpal Pharmaceuticals Limited on October 14, 2024 and sell it today you would earn a total of  3,080  from holding Jagsonpal Pharmaceuticals Limited or generate 16.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oil Natural Gas  vs.  Jagsonpal Pharmaceuticals Limi

 Performance 
       Timeline  
Oil Natural Gas 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oil Natural Gas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Oil Natural is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Jagsonpal Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jagsonpal Pharmaceuticals Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Jagsonpal Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Oil Natural and Jagsonpal Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oil Natural and Jagsonpal Pharmaceuticals

The main advantage of trading using opposite Oil Natural and Jagsonpal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oil Natural position performs unexpectedly, Jagsonpal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jagsonpal Pharmaceuticals will offset losses from the drop in Jagsonpal Pharmaceuticals' long position.
The idea behind Oil Natural Gas and Jagsonpal Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios